PET Imaging Agent Earns FDA Fast Track Designation in Recurrent Glioma
TLX101 is currently under assessment as a treatment for glioma in the IPAX-2 and IPAX-Linz studies.
TLX101 is currently under assessment as a treatment for glioma in the IPAX-2 and IPAX-Linz studies.
Precursor conditions are early phases of diseases that may develop into cancers such as lymphoma, leukemia, and multiple myeloma.
NOTCH3 signaling activates tumor-associated mesenchymal cells, increases collagen production, and augments cell invasion in lung adenocarcinoma, suggesting its critical role in remodeling tumor stroma.
Abstract. Advances in cancer prevention, early detection and treatments have led to unprecedented progress against cancer. However, these advances have not benefited everyone equally. Because…
Through clinical research led by our Katy Rezvani, M.D., Ph.D., CAR NK cell therapy has now become an experimental treatment option for multiple cancers . Learn…
The FDA has approved one of the first human papillomavirus self-collection solutions for use in the US.
Roche announced the FDA approval of its human papillomavirus (HPV) self-collection solution—one of the first of such tests available in the United States.
Samilia Obeng-Gyasi, MD, MPH, highlights a study on the association between neighborhood opportunity with all-cause mortality in patients with breast cancer.
AbstractBackground:. Distinguishing ovarian cancer from other gynecological malignancies is crucial for patient survival yet hindered by non-specific symptoms and limited understanding of ovarian cancer pathogenesis.…
The phase 2 VERSATILE-002 trial evaluating Versamune HPV with pembrolizumab met its primary end point in patients with first-line recurrent metastatic head and neck squamous…
In this issue of Blood, Kumar et al use a model antibody to show that a subpopulation of antiprothrombin antibodies found in people with antiphospholipid s